With American Family Care, the first care-delivery question is not which medication to choose. It is which clinic will actually provide the service. AFC’s national weight-management page describes local, in-person evaluation and follow-up, with GLP-1 treatment potentially available at selected locations. Denver Leetsdale goes further, advertising semaglutide and tirzepatide, compounded formulations, office injections and prepaid membership terms. Those local details create a more concrete picture of care, but they cannot be treated as a network-wide promise.
This review follows the handoffs a patient would need to understand: finding a participating clinic, meeting the treating team, receiving an evaluation, identifying the prescribed preparation, obtaining medication and arranging continuing support. Public documentation consulted October 19, 2026 establishes several of those steps, but leaves others unresolved. AFC’s strongest documented distinction is its emphasis on physical clinics rather than an entirely screen-based service. Its principal documentary weakness is that the full chain from prescriber to pharmacy to patient is not clearly identified.
At a glance
- Availability is local
- AFC says GLP-1 medications may be available at selected clinics, depending on location and medical eligibility; patients should confirm with their local center.Sources: [10]
- Evaluation precedes treatment
- The national program describes review of health history, goals and eligibility, followed by a personalized plan that may or may not include medication.Sources: [10]
- Denver’s advertised starting price
- Denver Leetsdale advertises semaglutide and tirzepatide starting at $160 per month; this is not a universal price for both medicines or every quantity.Sources: [5]
- Local prepaid memberships
- Leetsdale lists six-month memberships of $960 for semaglutide and $1,800 for tirzepatide, payable in full, including consultations, lab work and weigh-ins.Sources: [5]
- Cancellation condition
- The local six-month membership lists a $200 early-cancellation fee if canceled before three months. The consulted documentation does not establish a prepaid-balance refund policy.Sources: [5]
Start with the participating clinic, not the national footprint
AFC’s homepage advertises more than 400 clinics across 29 states. That footprint is not a map of confirmed GLP-1 access. Its weight-management page expressly limits possible medication availability to selected clinics and recommends contacting the local office. For someone planning care, the meaningful first confirmation is whether that particular location currently offers weight management, evaluates patients for GLP-1 treatment and accepts new participants—not merely whether an AFC clinic is nearby.
The organization also describes both company-owned and franchise locations, with franchise operators recruiting, hiring, training and managing their own employees. This helps explain why local arrangements matter. The national page supplies a broad care model; the Leetsdale page supplies specific plans and commercial terms. Neither establishes that another AFC location uses the same preparations, prices, appointment pattern or membership structure. Local confirmation should come before travel or payment.
Denver Leetsdale lists its address as 850 S Monaco Pkwy, Suite 10, Denver, CO 80224, and presents walk-in access, advance booking and a telemedicine booking option. Those access routes do not mean every weight-management step can occur remotely. The national program emphasizes in-person care, and the local monthly plan specifically describes office injections. Our care-journey guide offers a framework for separating appointment access from the later responsibilities of prescribing, dispensing and follow-up.
The evaluation is documented; the individual care team is not
AFC markets its national offering as “Physician-led Care,” with licensed providers rather than automated prescriptions. It says all patients receive an evaluation before treatment, reviewing health history, goals and eligibility. If medication is considered, factors include BMI, medical history and underlying conditions. These are AFC’s descriptions of its process, not independent verification of credentials. The consulted documentation does not identify the particular Leetsdale prescribers or their individual licenses.
The national page addresses adults seeking medically supervised weight management, including people wanting guidance beyond self-directed dieting. Medication is not required to participate: AFC also describes nutrition, activity and lifestyle-focused plans. It does not publish a complete set of numerical eligibility thresholds or medical exclusions in the consulted material. Separately, website terms concerning adult users and parental acceptance for minors govern website use; they should not be mistaken for clinical eligibility rules.
Leetsdale recommends diagnostic laboratory testing before medication and says testing can be performed on-site. The actual panel, whether every participant needs the same tests and the timing of results are not specified. A productive first-consultation preparation would therefore include asking who evaluates results, when a prescribing decision occurs and what happens if further assessment is needed. The documentation does not promise a same-day prescription or a defined treatment-start deadline.
The local product description needs a pharmacy-level explanation
The Leetsdale page advertises semaglutide and tirzepatide and states that it prescribes compounded GLP-1 agonists with B12 or an ingredient written as “Nianicimide.” That spelling should not be silently corrected or treated as a confirmed ingredient identity. Before agreeing to treatment, a patient needs the exact prescribed preparation, its ingredients, concentration and presentation explained by the treating team and dispensing pharmacy. The public wording does not resolve those details.
The distinction between the national and local descriptions is material. The national page discusses FDA-approved GLP-1 treatments generally, while Leetsdale explicitly advertises compounded preparations. FDA approval belongs to a specific product, not to AFC as a clinic network, and does not transfer to a compounded preparation. FDA says compounded drugs are not approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not demonstrate clinical inequivalence.
FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. The consulted AFC documentation does not name the compounding or dispensing pharmacy or describe its quality controls. That is an unresolved handoff, not proof of deficient dispensing. Our product-and-formulation checklist explains why knowing the ingredient name is only part of identifying what will actually be provided.
Office injections and a three-month visit option are different pathways
Leetsdale describes two visit arrangements: attending the center monthly or attending every three months. For the monthly arrangement, the page says appointments are in person because the patient receives the injection at the appointment, alongside a weight check. Payment is due at the initial consultation. The wording establishes an office-based component, but does not fully explain medication quantities, the complete administration schedule or what happens between those appointments.
For the three-month arrangement, patients can opt into a one-time nurse visit for injection education. That is a useful documented support option, but it does not settle whether medication is collected at the clinic, dispensed elsewhere or delivered. Nor does the duration of a visit plan establish a particular supply quantity. Patients should have the handling, administration education and between-visit contact arrangements explained without using this review to calculate or adjust medication doses.
No shipping policy, delivery charge, arrival window or cold-chain procedure is established in the consulted documentation. Those omissions matter only if a delivery pathway is actually offered; they should not be converted into a claim that AFC ships medication. If injectable medication is delivered, FDA explicitly advises not using a product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. The responsible contact should be identified before a shipment is expected.
What the local prices establish—and what the first payment must clarify
Leetsdale’s headline offer is “starting at $160” per month for its semaglutide and tirzepatide service. It is an entry price, not a fixed charge for either medicine at every quantity. Separately, the page promotes six-month memberships at $960 for semaglutide and $1,800 for tirzepatide, labels the promotion a 20% discount and requires full payment. The basis for that advertised discount is not adequately explained in the consulted documentation.
The membership expressly includes provider consultations, lab work and weigh-ins. However, the exact preparation and medication quantities covered by each prepaid offer remain unclear. The monthly arrangement’s statement that payment is due at the initial consultation does not establish that every patient must buy a six-month membership. Before paying, the useful document is an itemized explanation linking the selected plan, medication, included services and any additional charges.
The six-month membership also lists a $200 early-cancellation fee if canceled before three months. That clause does not establish a refund entitlement or explain how unused prepaid funds are handled. Automatic renewal, cancellation after the first three months and refund procedures are not specified. These are care-continuity questions as well as financial ones: a patient needs to know what happens to appointments, medication access and clinical support if the arrangement changes.
| Offer or term | Published detail | Clarification needed |
|---|---|---|
| Starting price | Semaglutide and tirzepatide advertised starting at $160 per month | Exact medicine, preparation and quantity at that price |
| Semaglutide membership | $960 for six months; full payment required | Medication quantities and basis of advertised 20% discount |
| Tirzepatide membership | $1,800 for six months; full payment required | Exact preparation and medication quantities included |
| Membership services | Provider consultations, lab work and weigh-ins included | Visit schedule, lab panel and any separate charges |
| Early cancellation | $200 fee if the six-month plan is canceled before three months | Refund treatment, unused balance and later cancellation terms |
Insurance acceptance does not complete the payment pathway
Denver’s insurance page lists multiple insurers, including Medicaid and Medicare, but frames that acceptance around urgent care services. It does not confirm payment for weight-management consultations, laboratory work or GLP-1 medication. The new-patient information likewise mentions self-pay rates for urgent care without establishing the weight program’s full charge structure. Patients should not infer that their usual urgent care billing arrangement carries over to the local membership.
NIDDK notes that some insurance plans cover weight-management medicines and some do not. For AFC, this means separating at least three questions: whether the clinic can bill a weight-management visit, whether the proposed tests are covered and whether the exact prescribed product is covered through the relevant pharmacy channel. A list of accepted carriers answers none of those questions conclusively. Confirmation should identify the specific service and product rather than simply the insurer’s name.
Follow-up is promised, but the response system needs definition
AFC’s national program describes follow-ups and adjustments as needed, while Leetsdale offers continuing help with clarification, motivation and medication adjustments. These statements support the presence of an intended ongoing-care relationship. They do not establish a response-time guarantee, a complete follow-up calendar or the channel for reaching the prescribing clinician between visits. Before enrollment, ask which team receives questions, how clinical concerns are escalated and whether additional appointments have separate charges.
The national page says GLP-1 medications require evaluation, monitoring and follow-up, and explicitly declines to guarantee particular weight-loss results. NIDDK similarly describes follow-up as involving response and tolerability, not merely renewed payments. AFC’s public material does not establish measured outcomes for this program. The relevant service question is therefore how the team reviews a patient’s experience and revisits the plan, rather than whether promotional language predicts a particular result.
Even arranging that follow-up requires checking local hours. Leetsdale’s weight-program page lists weekday hours of 8 a.m. to 8 p.m. and weekend hours of 8 a.m. to 6 p.m. Its insurance page instead lists weekdays until 5 p.m., Saturday until 4 p.m. and Sunday closure. The discrepancy is especially important for anyone expecting weekend care. Confirm both current opening hours and the narrower hours, if any, when the weight-management team is available.
Identify who is responsible beyond the AFC name
The website terms identify American Family Care, LLC as an Alabama limited liability company, but distinguish the website’s role from services provided by third parties. They describe connections with providers such as physicians, laboratories and pharmacies, with service scope governed by the patient’s relationship with those providers. The consulted documentation does not resolve the precise clinical operating entity for Leetsdale. A recognizable brand is therefore not a substitute for identifying the organization responsible for treatment.
This is where a pharmacy-handoff checklist becomes particularly useful: obtain the prescriber’s contact route, dispensing pharmacy’s identity and instructions for questions about the preparation. The terms also disclose website tracking technologies, including collection of appointment-booking activity, and restricted sharing of protected health information for functionality. Separately, replying STOP opts out of SMS messages; it does not cancel a clinical membership. Patients should distinguish clinical communication, website functions and contractual cancellation rather than assuming one action controls all three.
Questions & answers
Can I receive GLP-1 treatment at any AFC clinic?
No network-wide availability is established. AFC says GLP-1 medications may be available at selected clinics, depending on location and medical eligibility. Contact the specific center before booking for this purpose. Denver Leetsdale’s documented compounded-medication offers and membership prices should not be assumed to apply elsewhere. Even at a participating clinic, AFC describes evaluation before treatment rather than a guaranteed prescription.
Does Denver Leetsdale provide FDA-approved branded medication?
The local page advertises compounded GLP-1 preparations with B12 or an ingredient spelled “Nianicimide”; it does not identify a branded product in the consulted documentation. Ask for the exact preparation and pharmacy before payment. Compounded preparations are not FDA approved. FDA recommends their use when an individual’s medical needs cannot be met by an approved drug; that recommendation is not a finding about any particular AFC patient.
Will I need to visit the clinic for injections?
Leetsdale’s monthly arrangement explicitly describes in-person appointments to receive an injection and check weight. Its alternative involves visits every three months and an optional one-time nurse visit for injection education. The page does not fully establish dispensing, collection or delivery arrangements for that alternative. A telemedicine booking option should not be interpreted as confirmation that evaluation, medication administration and follow-up can all take place remotely.
What does the six-month membership include?
Leetsdale lists provider consultations, lab work and weigh-ins, with full payment required: $960 for semaglutide or $1,800 for tirzepatide over six months. It advertises a 20% discount without adequately explaining the comparison basis. The medication quantities and precise preparation included need confirmation. Ask for a written breakdown rather than assuming the membership duration guarantees a defined supply or that every possible service is included.
Does AFC’s acceptance of Medicare or Medicaid cover this program?
That is not established. Denver’s insurer list includes Medicare and Medicaid, but the page describes acceptance for urgent care services. It does not confirm coverage of weight-management visits, laboratory testing or the proposed medication. Ask the clinic and your plan about each component separately, identifying the exact service and preparation. An accepted insurance card is not confirmation that a prepaid weight-management membership will be reimbursed.
Can I cancel the membership and recover unused payments?
The published local clause establishes a $200 fee for canceling the six-month plan before three months, but does not explain refunds of unused prepaid funds, later cancellation conditions or automatic renewal. Obtain those terms before paying. Also ask how cancellation affects scheduled visits and ongoing clinical questions. Replying STOP to AFC text messages only opts out of SMS communications; it is not documented as a membership-cancellation method.
Our assessment
AFC documents a potentially useful alternative to a remote-only weight-management service: local evaluation, possible on-site testing, office-based treatment and an intended continuing relationship with a clinic team. Denver Leetsdale makes parts of that pathway tangible through its visit options, injection education and published membership prices. The limitations are equally concrete. Participating locations vary; the local preparations and dispensing pharmacy are not fully identified; membership supply and refund details remain unresolved; and conflicting office hours complicate practical access. The strongest basis for considering this service is a clinic-specific explanation that connects the treating professional, exact preparation, pharmacy, payment terms and follow-up contact into one understandable plan. The public documentation alone does not complete that chain or establish provider-specific treatment outcomes.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- American Family Care (AFC) — terms of use ↗
- American Family Care (AFC) — official website ↗
- American Family Care (AFC) — denver leetsdale/patient services/weight loss program fb ↗
- American Family Care (AFC) — denver leetsdale/resources/sms terms of service ↗
- American Family Care (AFC) — denver leetsdale/resources/new patient faqs ↗
- American Family Care (AFC) — denver leetsdale/resources/insurances accepted afc urgent care denver ↗
- American Family Care (AFC) — about us/careers ↗
- American Family Care (AFC) — patient services/weight management ↗